HRH2 and thanatophoric dysplasia: In addition, HRH2 regulates the production of arachidonic acid, one of the top metabolites emerging from the PRS-based analyses (see above) and it upregulates the expression of IL17A, a cytokine that itself has several interactions in the landscape and of which the blood levels were found to be increased in TD patients [271,272].